To send content items to your account,
please confirm that you agree to abide by our usage policies.
If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account.
Find out more about sending content to .
To send content items to your Kindle, first ensure email@example.com
is added to your Approved Personal Document E-mail List under your Personal Document Settings
on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part
of your Kindle email address below.
Find out more about sending to your Kindle.
Note you can select to send to either the @free.kindle.com or @kindle.com variations.
‘@free.kindle.com’ emails are free but can only be sent to your device when it is connected to wi-fi.
‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.
This chapter reviews the estimated thrombotic risks associated with the oestrogen content of combined hormonal contraception. Thrombotic diseases discussed in this chapter are arterial thrombosis and venous thrombosis. The risk of arterial thrombosis, including stroke and myocardial infarction, is reported to be increased in users of combined hormonal contraception. Such events may be fatal, or lead to disabling sequelae. While oestrogen may play a role in arterial thrombosis, the effect is primarily related to an interaction with traditional, and to some extent modifiable, risk factors for arterial disease. Venous thrombosis mostly manifests in the deep veins of the leg, but may occur in other sites, such as the upper extremities, cerebral sinus, liver and portal veins or retinal veins. The risk of venous thromboembolism (VTE) is strongly associated with age, obesity and in users of oral contraceptives (OCs). Pregnancy is a far more profound thrombophilia risk.